Glaukos (GKOS) Interest & Investment Income (2014 - 2026)
Glaukos' (GKOS) quarterly Interest & Investment Income came in at $2.4 million in Q1 2026, down 20.97% year-on-year from $3.1 million in Q1 2025, and down 3.22% on a QoQ basis from $2.5 million in Q4 2025.
Glaukos (GKOS) Interest & Investment Income (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Interest & Investment Income data on file, last reported at $2.4 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 20.97% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $10.1 million, a 9.27% decrease from a year earlier, with the FY2025 full-year figure at $10.7 million, down 3.52% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.4 million, down from $2.5 million in the prior quarter.
- Over the last five years, Interest & Investment Income for GKOS reached as high as $12.2 million in Q4 2022 and fell as low as -$5.9 million in Q2 2022.
- Historically, Interest & Investment Income has averaged $2.3 million across 5 years, with a median of $2.6 million in 2025.
- On a YoY basis, Interest & Investment Income climbed as much as 4373.16% in 2022 and fell as far as 1810.82% in 2022.
- Year by year, Interest & Investment Income stood at $12.2 million in 2022, then tumbled by 76.07% to $2.9 million in 2023, then decreased by 14.35% to $2.5 million in 2024, then increased by 0.72% to $2.5 million in 2025, then decreased by 3.22% to $2.4 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $2.4 million in Q1 2026, $2.5 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.43 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 2.49 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 12.17 Mn |
| Sep 30, 2022 | 744,000.00 |
| Jun 30, 2022 | -5.85 Mn |
| Mar 31, 2022 | -960,000.00 |
| Dec 31, 2021 | 272,000.00 |
| Sep 30, 2021 | 291,000.00 |
| Jun 30, 2021 | 342,000.00 |